Back

Lakewood-Amedex CEO to present Bisphosphocin data at three October conferences

Verifying
  • Lakewood-Amedex CEO Kelvin Cooper will participate in three October industry conferences.
  • Nu-3 preclinical data will be presented at IDWeek on October 22, 2026.
  • The company develops Bisphosphocin antimicrobials for infectious diseases and resistant bacterial strains.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.